Literature DB >> 1081163

A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations.

B H Cohen, W C Ball, W B Bias, S Brashears, G A Chase, E L Diamond, S H Hsu, P Kreiss, D A Levy, H A Menkes, S Permutt, M S Tockman.   

Abstract

Although certain environmental agents (e.g., cigarette smoking) are known to be causally related to chronic obstructive pulmonary disease (COPD), differential response to their deleterious effects suggests the importance of constitutional (host) factors. The voluminous literature on the familial occurrence of COPD as well as the association between genetically determined serum alpha 1-antitrypsin (alpha 1-at) deficiency and COPD, however, reveals many aspects yet to be clarified. Studies of alpha 1-at indicate that neither its nature nor its relationship to COPD is simple. Moreover, other familial factors are likely involved. To obtain a better understanding of the etiology and pathogenesis of COPD, both genetic and environmental factors are being examined in a multifaceted investigation. The preliminary observations are summarized. COPD patients have a higher frequency of Pi variant phenotypes than those without lung disease. Among other subjects, both cigarette smoking and Pi variant phenotypes are associated with increased pulmonary function abnormality. Finally, there is familial aggregation of pulmonary impairment that cannot be explained entirely by Pi type or smoking.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081163

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


  13 in total

1.  Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

Authors:  D L DeMeo; V J Carey; H A Chapman; J J Reilly; L C Ginns; F E Speizer; S T Weiss; E K Silverman
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

Review 2.  Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.

Authors:  N Kalsheker; K Morgan
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Specific diffusing capacity (DL/VA) as a measure of the lung's diffusing characteristics: prediction formulas for young adults.

Authors:  E Rosenberg; P Ernst; J Leech; M R Becklake
Journal:  Lung       Date:  1986       Impact factor: 2.584

4.  The relative contributions of nature and nurture in chronic obstructive pulmonary disease.

Authors:  A S Buist
Journal:  West J Med       Date:  1979-08

5.  Protease inhibitor profile of black Americans with and without chronic cardiopulmonary disease.

Authors:  R C Young; V E Headings; A L Henderson; S Bose; R L Hackney
Journal:  J Natl Med Assoc       Date:  1978-11       Impact factor: 1.798

Review 6.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.

Authors:  Ann G Schwartz; John C Ruckdeschel
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

7.  Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).

Authors:  S F Tattersall; R P Pereira; D Hunter; G Blundell; N B Pride
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

8.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Authors:  Antonello Punturieri; Eva Szabo; Thomas L Croxton; Steven D Shapiro; Steven M Dubinett
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

Review 9.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

Review 10.  Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease.

Authors:  Sean H Ling; Stephan F van Eeden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.